$30.6
Live
Revenue is up for the last 3 quarters, 295.76M → 348.20M (in $), with an average increase of 7.7% per quarter
Netprofit is down for the last 2 quarters, 14.62M → 13.17M (in $), with an average decrease of 9.9% per quarter
In the last 1 year, Fresenius Medical Care Ag & Co. Kgaa has given 57.8% return, outperforming this stock by 82.3%
0.92%
Downside
Day's Volatility :1.3%
Upside
0.39%
12.12%
Downside
52 Weeks Volatility :36.1%
Upside
27.28%
Period | Apollo Medical Holdings Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 3.62% | -0.3% | 0.0% |
6 Months | -21.59% | 2.8% | 2.0% |
1 Year | -24.45% | 7.7% | 6.8% |
3 Years | 74.67% | 27.0% | 19.9% |
Market Capitalization | 1.4B |
Book Value | $12.16 |
Dividend Share | 0.0 |
Dividend Yield | 0.0% |
Earnings Per Share (EPS) | 1.08 |
PE Ratio | 27.72 |
PEG Ratio | 0.0 |
Wall Street Target Price | 52.0 |
Profit Margin | 3.53% |
Operating Margin TTM | 8.64% |
Return On Assets TTM | 7.08% |
Return On Equity TTM | 9.55% |
Revenue TTM | 1.3B |
Revenue Per Share TTM | 28.3 |
Quarterly Revenue Growth YOY | 29.099999999999998% |
Gross Profit TTM | 199.5M |
EBITDA | 129.4M |
Diluted Eps TTM | 1.08 |
Quarterly Earnings Growth YOY | 0.08 |
EPS Estimate Current Year | 1.29 |
EPS Estimate Next Year | 1.57 |
EPS Estimate Current Quarter | 0.25 |
EPS Estimate Next Quarter | 0.42 |
What analysts predicted
Upside of 69.93%
FY17 | Y/Y Change | |
---|---|---|
Revenue | 356.2M | ↑ 520.29% |
Net Income | 25.8M | ↓ 387.65% |
Net Profit Margin | 7.24% | ↑ 22.86% |
FY18 | Y/Y Change | |
---|---|---|
Revenue | 514.7M | ↑ 44.49% |
Net Income | 10.8M | ↓ 58.01% |
Net Profit Margin | 2.11% | ↓ 5.13% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 555.4M | ↑ 7.91% |
Net Income | 14.1M | ↑ 30.29% |
Net Profit Margin | 2.54% | ↑ 0.43% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 682.2M | ↑ 22.83% |
Net Income | 37.9M | ↑ 168.24% |
Net Profit Margin | 5.55% | ↑ 3.01% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 767.4M | ↑ 12.48% |
Net Income | 73.9M | ↑ 95.05% |
Net Profit Margin | 9.62% | ↑ 4.07% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 1.1B | ↑ 49.1% |
Net Income | 49.0M | ↓ 33.59% |
Net Profit Margin | 4.29% | ↓ 5.33% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Revenue | 261.7M | ↑ 35.2% |
Net Income | 14.3M | ↑ 3.59% |
Net Profit Margin | 5.45% | ↓ 1.66% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 269.7M | ↑ 3.05% |
Net Income | 11.4M | ↓ 20.09% |
Net Profit Margin | 4.23% | ↓ 1.22% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 317.0M | ↑ 17.54% |
Net Income | 26.0M | ↑ 127.97% |
Net Profit Margin | 8.2% | ↑ 3.97% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 295.8M | ↓ 6.7% |
Net Income | -2.6M | ↓ 110.01% |
Net Profit Margin | -0.88% | ↓ 9.08% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 337.2M | ↑ 14.03% |
Net Income | 14.6M | ↓ 662.38% |
Net Profit Margin | 4.34% | ↑ 5.22% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 348.2M | ↑ 3.25% |
Net Income | 13.2M | ↓ 9.93% |
Net Profit Margin | 3.78% | ↓ 0.56% |
FY17 | Y/Y Change | |
---|---|---|
Total Assets | 490.6M | ↑ 2276.59% |
Total Liabilities | 154.3M | ↑ 657.44% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 513.0M | ↑ 4.56% |
Total Liabilities | 106.3M | ↓ 31.09% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 728.7M | ↑ 42.05% |
Total Liabilities | 367.7M | ↑ 245.74% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 817.5M | ↑ 12.18% |
Total Liabilities | 372.3M | ↑ 1.27% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 852.4M | ↑ 4.27% |
Total Liabilities | 391.9M | ↑ 5.25% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 963.9M | ↑ 13.09% |
Total Liabilities | 395.2M | ↑ 0.85% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 912.3M | ↑ 7.04% |
Total Liabilities | 380.7M | ↓ 2.86% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 951.1M | ↑ 4.25% |
Total Liabilities | 425.2M | ↑ 11.71% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 943.4M | ↓ 0.81% |
Total Liabilities | 390.1M | ↓ 8.26% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 963.9M | ↑ 2.17% |
Total Liabilities | 395.2M | ↑ 1.32% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 992.6M | ↑ 2.98% |
Total Liabilities | 414.7M | ↑ 4.93% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.0B | ↑ 3.48% |
Total Liabilities | 442.9M | ↑ 6.8% |
FY17 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 51.9M | ↓ 738.03% |
Investing Cash Flow | 8.0M | ↓ 672.91% |
Financing Cash Flow | -15.0M | ↓ 267.8% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 25.5M | ↓ 50.9% |
Investing Cash Flow | -25.2M | ↓ 415.94% |
Financing Cash Flow | -11.2M | ↓ 25.37% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 13.7M | ↓ 46.37% |
Investing Cash Flow | -180.6M | ↑ 617.28% |
Financing Cash Flow | 163.3M | ↓ 1561.4% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 46.2M | ↑ 237.61% |
Investing Cash Flow | 95.5M | ↓ 152.87% |
Financing Cash Flow | -51.7M | ↓ 131.65% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 70.3M | ↑ 52.36% |
Investing Cash Flow | 16.5M | ↓ 82.68% |
Financing Cash Flow | -47.7M | ↓ 7.64% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 82.1M | ↑ 16.77% |
Investing Cash Flow | -7.1M | ↓ 143.0% |
Financing Cash Flow | -20.1M | ↓ 57.94% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 24.0M | ↓ 297.19% |
Investing Cash Flow | -19.7M | ↓ 150.47% |
Financing Cash Flow | 532.0K | ↓ 62.93% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 9.0M | ↓ 62.47% |
Investing Cash Flow | 7.5M | ↓ 138.01% |
Financing Cash Flow | -20.2M | ↓ 3903.95% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -35.9M | ↓ 497.63% |
Investing Cash Flow | -8.1M | ↓ 207.86% |
Financing Cash Flow | -6.3M | ↓ 69.11% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 84.9M | ↓ 336.8% |
Investing Cash Flow | 13.2M | ↓ 263.26% |
Financing Cash Flow | -14.4M | ↑ 129.82% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 7.7M | ↓ 90.91% |
Investing Cash Flow | -14.0M | ↓ 206.32% |
Financing Cash Flow | -7.1M | ↓ 50.58% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 7.7M | ↑ 0.0% |
Investing Cash Flow | -14.0M | ↑ 0.0% |
Financing Cash Flow | -7.1M | ↑ 0.0% |
Sell
Neutral
Buy
Apollo Medical Holdings Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Apollo Medical Holdings Inc | -18.3% | -21.59% | -24.45% | 74.67% | 47.85% |
![]() Fresenius Medical Care Ag & Co. Kgaa | -6.57% | 7.56% | 57.77% | -47.04% | -56.96% |
![]() Hca Holdings, Inc. | -8.29% | 0.04% | 35.93% | 109.72% | 86.28% |
![]() Universal Health Services Inc. | -3.71% | 3.58% | 42.47% | 22.66% | 1.35% |
![]() Davita Healthcare Partners Inc. | -1.95% | 27.79% | 16.81% | 16.67% | 40.58% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Apollo Medical Holdings Inc | 27.72 | 27.72 | 0.0 | 1.29 | 0.1 | 0.07 | 0.0 | 12.16 |
![]() Fresenius Medical Care Ag & Co. Kgaa | 21.08 | 21.08 | 1.06 | 2.0 | 0.05 | 0.03 | 0.03 | 23.05 |
![]() Hca Holdings, Inc. | 12.46 | 12.46 | 1.37 | 18.44 | 0.21 | 0.11 | 0.01 | -8.44 |
![]() Universal Health Services Inc. | 13.2 | 13.2 | 1.87 | 10.19 | 0.11 | 0.05 | 0.01 | 87.72 |
![]() Davita Healthcare Partners Inc. | 20.02 | 20.02 | 0.86 | 7.21 | 0.29 | 0.05 | 0.0 | 11.15 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Apollo Medical Holdings Inc | Buy | $1.4B | 47.85% | 27.72 | 3.53% |
![]() Fresenius Medical Care Ag & Co. Kgaa | Hold | $13.2B | -56.96% | 21.08 | 3.04% |
![]() Hca Holdings, Inc. | Buy | $68.6B | 86.28% | 12.46 | 9.32% |
![]() Universal Health Services Inc. | Hold | $8.8B | 1.35% | 13.2 | 5.02% |
![]() Davita Healthcare Partners Inc. | Hold | $9.0B | 40.58% | 20.02 | 3.98% |
BlackRock Inc
Vanguard Group Inc
State Street Corporation
Geode Capital Management, LLC
Dimensional Fund Advisors, Inc.
325 Capital LLC
apollo medical holdings, inc., a physician-centric technology-powered healthcare management company, provides medical care services. the company, leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver quality care to its patients. it offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. the company's physician network consists of primary care physicians, specialist physicians, and hospitalists. it caters to patients, primarily covered by private or public insurance, such as medicare, medicaid, and health maintenance organization plans; and non-insured patients in california. apollo medical holdings, inc. was founded in 1994 and is headquartered in alhambra, california.
Organization | Apollo Medical Holdings Inc |
Employees | 1362 |
CEO | Dr. Kenneth T. Sim M.D. |
Industry | Health Services |
Farmers National Banc Corp
$30.60
-0.07%
Revance Therapeutics Inc
$30.60
-0.07%
X-links Slvr Shrs Covrd Call
$30.60
-0.07%
Bny Mellon Ultra Short Income Etf
$30.60
-0.07%
Xeris Biopharma Holdings Inc
$30.60
-0.07%
Columbia Financial Inc
$30.60
-0.07%
Rumbleon Inc
$30.60
-0.07%
Innovator Growth-100 Power Buffer Etf - April
$30.60
-0.07%
Stealthgas Inc
$30.60
-0.07%